Cited by 200Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchAsthma and respiratory diseases

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

Durham, Stephen R., Penagos, Martin·2016·Journal of Allergy and Clinical Immunology

Abstract

Allergen immunotherapy is effective in patients with allergic rhinitis (AR) and, unlike antiallergic drugs, has been shown to modify the underlying cause of the disease, with proved long-term benefits. Subcutaneous immunotherapy (SCIT) has been the gold standard, whereas sublingual immunotherapy (SLIT) has emerged as an effective and safe alternative. Previous Cochrane systematic reviews and meta-analyses have confirmed that both SLIT and SCIT are effective in patients with seasonal AR, whereas evidence for their efficacy in patients with perennial disease has been less convincing. Recent large, adequately powered trials have demonstrated reductions in both symptoms and use of rescue medication in patients with seasonal and those with perennial AR. Here we appraise evidence for SCIT versus SLIT based on indirect evidence from Cochrane reviews and recent well-powered double-blind, randomized controlled trials versus placebo and the limited direct evidence available from randomized blind head-to-head comparisons. At present, based on an overall balance of efficacy and side effects, the patient is in equipoise. Pending definitive comparative trials, choice might be determined largely by the local availability of SCIT and SLIT products of proved value and personal (patient) preference.

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2015.12.1298

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Specific data on nasal obstruction are not usually published in systematic reviews and meta-analyses of subcutaneous and sublingual immunotherapy.

    “Total symptom score is the main variable in systematic reviews and meta-analyses, both in SCIT [172] and in SLIT in drops [173] or in tablets [174]; therefore, specific data on NO are not usually published [171].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [171]

  • Subcutaneous immunotherapy and sublingual immunotherapy are effective in reducing symptoms, including nasal obstruction, of seasonal and perennial allergic rhinitis.

    “Both subcutaneous immunotherapy (SCIT) [168] and sublingual immunotherapy (SLIT) [169,170] have proven effective in reducing the symptoms (including NO) of seasonal and perennial AR [171].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [171]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Durham, S. R., & Penagos, M.
Affiliations
Imperial College London (GB)
Corresponding author
Durham, Stephen R.
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2016-02
Volume
137
Issue
2
Pages
339-349.e10
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2271602246
Cited by
200
References
6
Citations by year
2026: 2 · 2025: 12 · 2024: 19 · 2023: 20 · 2022: 27 · 2021: 21 · 2020: 24 · 2019: 18 · 2018: 19 · 2017: 26 · 2016: 11
FWCI
3.66
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
allergic rhinitis, sublingual immunotherapy, subcutaneous immunotherapy, allergen immunotherapy, perennial allergic rhinitis, rescue medication use, treatment efficacy, adverse effects, head-to-head comparison
MeSH terms
Administration, Sublingual, Allergens, Desensitization, Immunologic, Humans, Injections, Subcutaneous, Treatment Outcome, Sublingual Immunotherapy, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review